Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension

International Journal of Cardiology

Volumn 147, Issue 3, 2011, Pages 433-437

  Zhang, Duan Zhen ^a   Zhu, Xian Yang ^a   Meng, Jing ^a   Xue, Hong Mei ^a   Sheng, Xiao Tang ^a   Han, Xiu Min ^a   Cui, Chun Sheng ^a   Wang, Qi Guang ^a   Zhang, Po ^a  

^a SHENYANG NORTHERN HOSPITAL   (China)

Author keywords

Congenital heart defect; Hemodynamics; Pulmonary arterial hypertension; Vasoreactivity test

Indexed keywords

ADENOSINE; ILOPROST;

ADULT; AORTA PRESSURE; ARTERIAL PRESSURE; ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG POTENCY; DYSPNEA; HEART ATRIUM SEPTUM DEFECT; HEART HEMODYNAMICS; HEART PALPITATION; HEART RATE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LUNG GAS EXCHANGE; LUNG PRESSURE; MAJOR CLINICAL STUDY; OXYGEN SATURATION; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; VASCULAR RESISTANCE;

ACUTE DISEASE; ADENOSINE; ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; CHILD; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFUSIONS, INTRAVENOUS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 79952489220     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.04.093     Document Type: Article

References (25)

1. R.L. Benza, B.K. Rayburn, and J.A. Tallaj Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease Chest 129 2006 1009 1015
2. S.C. Apostolopoulou, A. Manginas, D.V. Cokkinos, and S. Rammos Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study Heart 93 2007 350 354 (Pubitemid 46579526)
3. N. Galiè, M. Beghetti, and M.A. Gatzoulis Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Circulation 114 2006 48 54
4. R. Voswinckel, B. Enke, and F. Reichenberger Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies J Am Coll Cardiol 48 2006 1672 1681 (Pubitemid 44528194)
5. J. Pepke-Zaba, C. Gilbert, L. Collings, and M.C. Brown Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension Chest 133 2008 183 189
6. G.P. Ussia, M. Mulè, E. Caruso, R. Aiello, and C. Tamburino Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension Int J Cardiol 116 2007 427 429 (Pubitemid 46283029)
7. M.M. Hoeper, H. Olschewski, and H.A. Ghofrani A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension J Am Coll Cardiol 35 2000 176 182 (Pubitemid 30061277)
8. Z.C. Jing, X. Jiang, and Z.Y. Han Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension Eur Respir J 33 2009 1354 1360
9. A. Limsuwan, A. Khosithseth, S. Wanichkul, and P. Khowsathit Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease Catheter Cardiovasc Interv 73 2009 98 104
10. M. Berner, M. Beghetti, I. Spahr-Schopfer, I. Oberhansli, and B. Friedli Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease Am J Cardiol 77 1996 532 535 (Pubitemid 26086648)
11. R.W. Day, J.M. Lynch, R.E. Shaddy, and G.S. Orsmond Pulmonary vasodilatory effects of 12 and 60 parts per million inhaled nitric oxide in children with ventricular septal defect Am J Cardiol 75 1995 196 198
12. J.D. Roberts Jr., P. Lang, L.M. Bigatello, G.J. Vlahakes, and W.M. Zapol Inhaled nitric oxide in congenital heart disease Circulation 87 1993 447 453 (Pubitemid 23040914)
13. C.F. Opitz, R. Wensel, and M. Bettmann Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation Eur Heart J 24 2003 356 365 (Pubitemid 36215969)
14. B.J. Schrader, S. Inbar, L. Kaufmann, R.E. Vestal, and S. Rich Comparison of the effects of adenosine and nifedipine in pulmonary hypertension J Am Coll Cardiol 19 1992 1060 1064
15. Z. Tian, T.B. Chen, and Q. Fang Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases Zhonghua Yi Xue Za Zhi 89 2009 2099 2102
16. O. Hallioglu, E. Dilber, and A. Celiker Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease Am J Cardiol 92 2003 1007 1009 (Pubitemid 37214824)
17. A. Sablotzki, T. Hentschel, and E. Gruenig Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance Eur J Cardiothorac Surg 22 2002 746 752 (Pubitemid 35300117)
18. H.A. Ghofrani, G. Friese, and T. Discher Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension Eur Respir J 23 2004 321 326 (Pubitemid 38202132)
19. P.C. Rimensberger, I. Spahr-Schopfer, and M. Berner Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms Circ 103 2001 544 548 (Pubitemid 32116239)
20. R.J. Barst, G. Maislin, and A.P. Fishman Vasodilator therapy for primary pulmonary hypertension in children Circulation 99 1999 1197 1208
21. O. Sitbon, M. Humbert, and J.L. Jagot Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension Eur Respir J 12 1998 265 270 (Pubitemid 28389516)
22. N. Galiè, A. Torbicki, and R. Barst Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur Heart J 25 2004 2243 2278
23. D.B. Badesch, S.H. Abman, G. Simonneau, L.J. Rubin, and V.V. McLaughlin Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines Chest 131 2007 1917 1928 (Pubitemid 46981654)
24. M. Emmel, B. Keuth, and S. Schickendantz Paradoxical increase of pulmonary vascular resistance during testing of inhaled iloprost Heart 90 2004 e2
25. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150